NLRP3 and neoplasm: None of the immune markers demonstrated a correlation with hearing function as an indicator of tumor induced neuropathy, a finding consistent with the majority of published literature, which highlights only isolated targets such as NLRP3 inflammasomes as correlating with hearing function (23).